These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8104966)

  • 21. Duration of the effect of a single dose of azelastine on histamine-induced bronchoconstriction.
    Magnussen H; Reuss G; Jörres R; Aurich R
    J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):467-71. PubMed ID: 2563744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses.
    Henz BM; Metzenauer P; O'Keefe E; Zuberbier T
    Allergy; 1998 Feb; 53(2):180-3. PubMed ID: 9534917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of H1-receptor blockade on the development of early- and late-phase bronchoconstriction and increased bronchial responsiveness in allergen-induced asthma.
    Twentyman OP; Ollier S; Holgate ST
    J Allergy Clin Immunol; 1993 Jun; 91(6):1169-78. PubMed ID: 8099592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
    McTavish D; Sorkin EM
    Drugs; 1989 Nov; 38(5):778-800. PubMed ID: 2574665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W; Wiseman LR
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo.
    Gehanno P; Deschamps E; Garay E; Baehre M; Garay RP
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(2):76-81. PubMed ID: 11244365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitory actions of azelastine hydrochloride on the early and late bronchoconstrictor responses to inhaled allergen in atopic asthma.
    Rafferty P; Ng WH; Phillips G; Clough J; Church MK; Aurich R; Ollier S; Holgate ST
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):649-57. PubMed ID: 2572616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L; Andersson M; Svensson C; Persson CG
    Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
    Pipkorn P; Costantini C; Reynolds C; Wall M; Drake M; Sanico A; Proud D; Togias A
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis].
    Arcimowicz M; Samoliński B; Zawisza E
    Pol Merkur Lekarski; 1998 Dec; 5(30):363-7. PubMed ID: 10101526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the efficacy of azelastine nasal spray and loratidine tablets in the treatment of seasonal allergic rhinitis.
    Gambardella R
    J Int Med Res; 1993; 21(5):268-75. PubMed ID: 7906659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
    Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
    Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H1-antihistamines for primary mast cell activation syndromes: a systematic review.
    Nurmatov UB; Rhatigan E; Simons FE; Sheikh A
    Allergy; 2015 Sep; 70(9):1052-61. PubMed ID: 26095756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose related protective effect of azelastine on histamine induced bronchoconstriction in extrinsic asthma.
    Bauer K; Aurich R; Kaik G
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):333-8. PubMed ID: 1980266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of azelastine on substance P-induced itch-associated response in mice.
    Andoh T; Kuraishi Y
    Eur J Pharmacol; 2002 Feb; 436(3):235-9. PubMed ID: 11858803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.